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Abstract
Background: Hepatitis C virus (HCV) is a common chronic infection that is widely associated with symptoms of fatigue
and abdominal pain. The aim of the present study was to determine the prevalence of functional dyspepsia (FD)
among patients with hepatitis C.
Methods: This study included 252 patients with chronic hepatitis C and 150 healthy volunteers. Clinical and laboratory
data were recorded for every patient. All patients and controls were administered a questionnaire of FD according to
Rome III criteria.
Results: The percentage of patients with FD was significantly higher in patients with chronic HCV than normal controls
(65.9 % vs 28.7 %, respectively). In chronic HCV patients, post prandial distention syndrome (PDS) subtype was the
predominant type (86.1 %). The percentage of patients with a high fibrosis score (F2–3) and raised ALT were significantly
higher in patients with FD than in patients without FD (P < 0.001; P < 0.04; respectively). A multivariate regression analysis
revealed a significant association between fibrosis score, BMI and FD
Conclusion: FD is more prevalent in patients with chronic hepatitis C. Obese chronic HCV and those with higher fibrosis
scores are more likely to have FD.
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Background
FD is a clinical syndrome defined by unexplained
chronic or recurrent upper abdominal symptoms [1].
Symptoms are frequently related to meals and include
epigastric pain, early satiety, fullness or bloating, belch-
ing, nausea and vomiting. In previous report abdominal
pain, nausea, bloating, and early satiety were found to
occur more frequently in patients with chronic liver
disease compared to healthy controls [2]. According to
another study, dyspeptic symptoms without any appar-
ent organic cause were reported by 28/62 patients with
cirrhosis [3].
The most widely applied criteria used in previous stud-
ies were Rome I and Rome II criteria. Due to the strict cri-
teria in Rome II; new Rome III criteria was introduced. In
Rome III criteria two subtypes of FD were identified
epigastric pain syndrome (EPS) and post prandial distress
syndrome (PDS) [4]. little is known about these subtypes
especially in our Egyptian community.
Functional dyspepsia have been studied in patients
with hepatitis C [5], but no published data are yet avail-
able about the possible association between FD and
chronic HCV infection. The aim of this study was to in-
vestigate the possible association between chronic hepa-
titis C and FD.
Methods
This study was under taken at the Virology and Hepatol-
ogy clinic of Minia University Hospital, Minia, Egypt. The
study was approved by the institutional review board of
the Minia Faculty of Medicine, Minya University, Egypt.
Written, informed consent was obtained from every par-
ticipant (for both participation in the study and publica-
tion of the data). In total, 252 consecutive patients with
chronic hepatitis C genotype 4, diagnosed by HCV-RNA
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and liver biopsy using the Metavir score, were enrolled in
the study. One hundred and fifty controls were randomly
selected from healthy volunteer (medical officer, nurses,
medical staff and medical students. They were matched in
age and sex to the patients. All patients and controls were
requested to fill out a self-report questionnaire. The ques-
tionnaires were dispensed to patients and controls by the
researchers. They were requested to consult the doctor if
they did not understand a question in the questionnaire.
A researcher assisted those with literacy difficulties.
The validated Rome III diagnostic questionnaire for FD
was designed by the Rome committee. The FBDs module
was downloaded from the Rome Foundation website
(http://www.romecriteria.org/questionnaires/).
FD patients were classified into two subtypes PDS and
EPS. PDS must include all of the following: Bothersome
postprandial fullness, occurring after ordinary sized meals,
at least several times per week. Early satiation that pre-
vents finishing a regular meal, at least several times per
week. EPS must include all of the following: 1) Pain or
burning localized to the epigastrium, of at least moderate
severity at least once per week, 2) The pain is intermittent,
3) Not generalized or localized to other abdominal or
chest regions, 4) Not relieved by defecation or passage of
flatus, 5) Not fulfilling criteria for biliary pain, 6) Criteria
fulfilled for the last 3 months with symptom onset at least
6 months prior to diagnosis..
The alarm (or red flags symptoms) are also included in
the questionnaire. The presence of alarm symptoms as
melena, hematemesis, loss of weight, history of gastric
cancer potentially indicative of organic diseases that war-
rant further investigations and necessitates for further
evaluation.
In addition to that the psychological alarm questionnaire
which help to detect associated psychological problems re-
lated to FD. The questions include anxiety, depressive
symptoms, suicidal ideation, severity of pain, physical im-
pairment and abuse behavior. Patients who fulfilled the cri-
teria for FD based on Romi III questionnaire were referred
to endoscopy to rule out the organic cause.
Statistical analysis
Statistical analysis was applied using Graph pad prism
software with curve fitting version 4 and SPSS computer
program (version 13 windows). Contingency tables used
(chi square and Fisher’s tests) for binomial variables and
T test and AVOVA tests for the other variables. Multi-
variate regression analysis was done. P value equal to or
less than 0.05 was considered significant. Results were
expressed as mean ± SD unless otherwise stated.
Results
Total of 272 HCV patients and 150 normal controls pa-
tients were studied. Twenty one patients were non
responders as they did not complete the questionnaire
(10 patients) and refusing endoscopy (11 patients). Of
the 251 HCV infected patients were included in the
study; 187 fulfilled the criteria of functional dyspepsia and
underwent upper endoscopy. One hundred sixty six had
normal endoscopy and were diagnosed as having func-
tional dyspepsia, 5 subjects had lower esophagitis, 8 pa-
tients had gastro esophageal reflux disease, 6 subjects had
antral gastritis and duodenal ulcer recorded in 2 patients
There was significant difference in the demographics be-
tween the control groups and the HCV group with regard
to age, sex, smoking and BMI (P < 0.001; P < 0.0001;
P < 0.0001; P < 0.003, respectively),other socio-demographics
character of the precipitants was shown in (Table 1).
The percentage of patients with FD diagnosed accord-
ing to Rome III criteria were significantly higher in pa-
tients with chronic HCV infection than normal controls
(65.9 %, 28.7 %; respectively; P < 0.0001) Fig. 1. Regard-
ing to functional dyspepsia subtypes, the PDS subtype
was significantly predominant than The EPS one in both
patients and controls (P < 0.005, P < 0.03) (Table 2).
To study the possible risk factors of FD in patients
with chronic HCV, we compared patients with FD to
those without. It was found that ALT level and fibrosis
stages were significantly higher in patients with FD than








Age (mean ± SD) 45.5 ± 8.08 33.6 ± 12.09 <0.001*
Sex <0.0001*
Male 161 (63.9 %) 53 (35.3 %)
Female 91 (36.1 %) 97 (64.7 %)
Residence <0.9
Urban 156 (61.9 %) 93 (62 %)
Rural 96 (38.1 %) 57 (38 %)
Years of education (Mean ± SD) 9.70 ± 2.9 10.4 ± 1.8 <0.13
Smoking <0.0001*
Yes 138 (54.8 %) 13 (8.7 %)
No 114 (45.2 %) 137 (91.3 %)
BMI (kg/m2) 29.4 ± 3.9 23.9 ± 3.5 <0.003*
Red flag symptoms <0.09
Yes 10 (4 %) 2 (1.3 %)
No 242 (96 %) 148 (98.7 %)
Psycho-social symptoms <0.2
Yes 9 (3.6 %) 12 (8 %)
No 243 (96.4 %) 138 (92 %)
HCV hepatitis C virus, BMI body mass index, FD functional dyspepsia
*Statistically significant
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in patients without (P < 0.04, P < 0.0001), there was no
significant difference in HCV viral load in patients with
FD than in patients without (P < 0.2) (Table 3).
Multivariate regression analysis was done to clarify the
association between patient’s risk factors and functional
dyspepsia. The most important predictors of FD in HCV
patients were BMI (P < 0.01) and fibrosis stage (P < 0.001).
There was no significant association between age, sex,
smoking, ALT, HCV viraemia and FD (Table 4).
Discussion
Patients with Chronic hepatitis C usually have different
abdominal complaints. Abdominal pain or discomfort is
frequently seen in clinical practice in patients with chronic
HCV without organic lesion, the functional origin of ab-
dominal complaints is claimed in many patients [6].
We have seen this association frequently in clinical prac-
tice, but this is the first designed study to investigate the
possible association between FD and chronic hepatitis C.
In this study, the prevalence of FD was significantly high
in HCV patients than healthy controls (65.9 % vs 28.7 %).
It was found that the majority of the HCV infected pa-
tients in this study had symptoms of PDS which consti-
tuted about 86.1 % of them while 13.9 % of patients
had EPS.
This finding was similar to most studies performed as
a population based research. Aro et al. [7] in Sweden
who found that PDS was more prevalent than EPS.
These findings indicate that patients with liver disease
have meal-related symptoms that may be under recog-
nized. Further investigational studies of gastric neuro-
muscular function, such as gastric emptying studies and
electrogastrogram testing, are warranted. Intestinal mo-
tility disorders have been described in cirrhosis but not
previously reported or studied in chronic hepatitis [8].
Alternative explanations for these postprandial symp-
toms might include meal-related increases to portal
blood flow and volume changes. Duplex ultrasound and
MRI have shown that patients with chronic hepatitis C
have a greater volume change to the left lobe of the liver
with a relatively smaller change in portal blood flow than
do controls [9].
Theoretically, portal flow and volume changes in pa-
tients with inflammatory conditions of the liver may re-
sult in more congestion and subsequent stretch of
Glisson’s capsule, in turn leading to more stimulation of
hepatic vagal afferent activity with resultant symptoms
of postprandial pain, nausea, and fullness [10].
Grassi et al., reported FD in 28.8 % of patients with
chronic liver diseases and 71.2 % had organic cause of
Fig. 1 Prevalence of Functional dyspepsia in patients with chronic hepatitis C. Percentage of patients with FD diagnosed according to Rome III
criteria was significantly higher in patients with chronic hepatitis C virus (65.9 %) than in controls (28.7 %)
Table 2 Prevalence of functional dyspepsia subtypes among
HCV patients and controls
Parameter HCV positive patients Normal controls
n = 166 n = 43
Patients with PDS 153 (86.1 %) 28 (65.1 %)
Patients with EPS 13 (13.9 %) 15 (34.9 %)
P value <0.005** <0.03**
HCV Hepatitis C virus; PDS Post prandial distress syndrome; EPS Epigastric
pain syndrome
**Statistically significant
Table 3 Biochemical, serological and pathological characteristics
of HCV patients with functional dyspepsia
Parameter Patients with FD Patients without FD P-Value
166 86
Serum ALT
Normal 9 (45 %) 11 (55 %) <0.04*
Elevated 157 (67.7 %) 75 (32.3 %)
Fibrosis score <0.0001*
F0-F1 13 (37.1 %) 22 (62.9 %)
F2-F3 153 (70.5 %) 64 (29.5 %)
HCV RNA (PCR) <0.2
Median 147,160 180,603
Range (1000–2 220 000) (800–4 080 000)
ALT alanine transaminase; FD functional dyspepsia; PCR Polymerase chain reaction
*Statistically significant
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dyspepsia as gastroesophageal reflux disease, congestive
gastropathy, gastric or duodenal ulcer and gallbladder
stones. Severity of dyspeptic symptoms was similar in
both organic and functional forms; symptoms tend to
occur with moderate intensity, worsening in parallel
with the aggravation of liver disease. The predominance
of functional forms in liver diseases is practically the
same as that reported in the general population [11].
By multivariate analysis, the most important factors
that predicts FD were BMI and fibrosis scores. While
gender, age, residence, smoking and viral load were not
significantly associated. Aro et al. demonstrated that
obesity (BMI > 30 kg/m2) was predictive for uninvesti-
gated FD but no significant association between obesity
and FD [7].
A higher fibrosis scores in HCV patients with FD
can indicate a prolonged duration of HCV infection
and associated motor or inflammatory changes in the
bowel mucosa. Previous studies indicated that patients
with cirrhosis were found to have increased severity of
gastrointestinal symptoms correlating with the severity
but not the etiology of the liver disease [12]. This means
that increasing grade of fibrosis is associated with increase
occurrence of FD this may occur as a result of immuno-
logical changes that occur with advanced liver diseases.
Gastrointestinal sensorimotor disturbances have previ-
ously been reported in patients with cirrhosis and might
be involved in the pathogenesis of gastrointestinal symp-
toms in these patients.
In summary FD is a prevalent finding in HCV patients
and its pattern is not different from that of the general
population.
Conclusion
FD is more prevalent in patients with chronic hepatitis
C. Obese, chronic HCV patients and those with higher
fibrosis scores are more likely to have FD. Further stud-
ies are needed to determine why. Is infectious pathogen-
esis, motor dysfunction, or psychological disturbance?.
Limitation of the study: as this study employed ques-
tionnaire method for data collection it might lead to recall
bias and language bias. Also some subjects in this study
had actually being treated for their dyspeptic symptoms
and this would change the course of the symptoms and
could affect the true prevalence of FD.
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